LEDGF: a leukemia-specific target

摘要

In this issue of Blood, El Ashkar et al(1) reveal that the lens epithelium-derived growth factor (LEDGF) protein is a key therapeutic target by showing that it is essential for leukemia, but not normal hematopoiesis. Such context-dependent information is important for the development of new targeted therapies.